Activity of Antimicrobial Combinations against KPC-2-Producing Klebsiella pneumoniae in a Rat Model and Time-Kill Assay

被引：28
|
作者：
Michelon Toledo, Paula Virginia [1 ,2 ]
Aranha Junior, Ayrton Alves [2 ,3 ]
Arend, Lavinia Nery [4 ]
Ribeiro, Vanessa [5 ]
Zavascki, Alexandre Prehn [5 ]
Tuon, Felipe Francisco [1 ,6 ]
机构：
[1] Univ Fed Parana, Internal Med Postgrad Training, BR-80060000 Curitiba, Parana, Brazil
[2] Univ Estadual Ponta Grossa, Dept Med, Ponta Grossa, Brazil
[3] Univ Fed Parana, Dept Anat, BR-80060000 Curitiba, Parana, Brazil
[4] Bacteriol Sect, Lab Cent Saude Publ Estado LACEN PR, Curitiba, Parana, Brazil
[5] Hosp Clin Porto Alegre, Infect Dis Serv, Porto Alegre, RS, Brazil
[6] Hosp Univ Evangel Curitiba, Div Infect & Parasit Dis, Curitiba, Parana, Brazil
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2015年 / 59卷 / 07期
关键词：
POLYMYXIN-B; TIGECYCLINE; INFECTIONS; MEROPENEM; MORTALITY; EFFICACY; GLYCYLCYCLINE; GENTAMICIN; PREDICTORS; BACTEREMIA;
D O I：
10.1128/AAC.00323-15
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
This study evaluated the efficacy of tigecycline (TIG), polymyxin B (PMB), and meropenem (MER) in 80 rats challenged with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae infection. A time-kill assay was performed with the same strain. Triple therapy and PMB + TIG were synergistic, promoted 100% survival, and produced negative peritoneal cultures, while MER + TIG showed lower survival and higher culture positivity than other regimens (P = 0.018) and was antagonistic. In vivo and in vitro studies showed that combined regimens, except MER + TIG, were more effective than monotherapies for this KPC-producing strain.
引用
下载
收藏
页码：4301 / 4304
页数：4
相关论文
共 50 条
  • [41] Molecular epidemiology of KPC-2-producing Klebsiella pneumoniae isolates in Brazil: the predominance of sequence type 437
    Seki, Liliane M.
    Pereira, Polyana S.
    de Souza, Maria da Penha A. H.
    Conceicao, Magda de S.
    Marques, Elizabeth A.
    Porto, Carlos Oliveira
    Colnago, Elvira Maria L.
    Alves, Carlene de F. M.
    Gomes, Deize
    Carvalho Assef, Ana Paula D. A.
    Samuelsen, Orjan
    Asensi, Marise D.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2011, 70 (02) : 274 - 277
  • [42] In Vitro and In Vivo Synergism of Fosfomycin in Combination with Meropenem or Polymyxin B against KPC-2-Producing Klebsiella pneumoniae Clinical Isolates
    Ribeiro, Aghata Cardoso da Silva
    Chikhani, Yohanna Carvalho dos Santos Aoun
    Valiatti, Tiago Barcelos
    Valencio, Andre
    Kurihara, Mariana Neri Lucas
    Santos, Fernanda Fernandes
    Minarini, Luciene Andrade da Rocha
    Gales, Ana Cristina
    ANTIBIOTICS-BASEL, 2023, 12 (02):
  • [43] First Outbreak of KPC-2-Producing Klebsiella pneumoniae Sequence Type 258 in a Hospital in South Korea
    Hong, Sung Kwan
    Yong, Dongeun
    Kim, Kyeongmi
    Hong, Sang Sook
    Hong, Seong Geun
    Khosbayar, Tulgaa
    Song, Wonkeun
    Roh, Kyoung Ho
    Jeong, Seok Hoon
    Lee, Kyungwon
    Chong, Yunsop
    JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (11) : 3877 - 3879
  • [44] Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae
    M. Souli
    I. Karaiskos
    A. Masgala
    L. Galani
    E. Barmpouti
    H. Giamarellou
    European Journal of Clinical Microbiology & Infectious Diseases, 2017, 36 : 1305 - 1315
  • [45] Expansion of Clonal Complex 258 KPC-2-Producing Klebsiella pneumoniae in Latin American Hospitals: Report of the SENTRY Antimicrobial Surveillance Program
    Castanheira, Mariana
    Costello, Andrew J.
    Deshpande, Lalitagauri M.
    Jones, Ronald N.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (03) : 1668 - 1669
  • [46] Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae
    Souli, M.
    Karaiskos, I.
    Masgala, A.
    Galani, L.
    Barmpouti, E.
    Giamarellou, H.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2017, 36 (07) : 1305 - 1315
  • [47] Evaluation of Double- and Triple-Antibiotic Combinations for VIM- and NDM-Producing Klebsiella pneumoniae by In Vitro Time-Kill Experiments
    Tangden, T.
    Hickman, R. A.
    Forsberg, P.
    Lagerback, P.
    Giske, C. G.
    Cars, O.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (03) : 1757 - 1762
  • [48] Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae
    Kim, BN
    Woo, JH
    Kim, YS
    Ryu, J
    Kim, MN
    Pai, CH
    CHEMOTHERAPY, 2000, 46 (05) : 303 - 308
  • [49] PLAZOMICIN IN VITRO ACTIVITY AGAINST GLOBAL KPC-PRODUCING KLEBSIELLA PNEUMONIAE ISOLATES
    Castanheira, Mariana
    Deshpande, Lalitagauri
    Yee, Cheung
    Das, Sandhya
    Gogtay, Jaideep
    Mendes, Rodrigo
    Sader, Helio
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 328 - 328
  • [50] Early Dissemination of IncQ1 Plasmids in KPC-2-Producing Klebsiella pneumoniae CG258
    Campos, Paola A.
    Fuga, Bruna
    Cerdeira, Louise T.
    Ferreira, Melina L.
    Dias, Vinicius L.
    Machado, Luiz G.
    Rossi, Iara
    Lincopan, Nilton
    Gontijo-Filho, Paulo P.
    Ribas, Rosineide M.
    MICROBIAL DRUG RESISTANCE, 2019, 25 (08) : 1257 - 1259
12345